XML 21 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities:      
Net loss $ (12,308) $ (10,310) $ (6,697)
Adjustments to reconcile net loss to net cash used in operating activities:      
Write-off of inventory 597
Depreciation and amortization 78 39 47
Change in fair value of convertible preferred stock warrant liability (250) (274)
Change in fair value of maturity date preferred stock warrant liability (10) (87)
Change in fair value of convertible shareholder notes derivative liability 1,224 (1,373)
Share-based compensation 2,707 942 283
Non-cash interest expense on convertible shareholder notes 1,736 1,387
Changes in operating assets and liabilities:      
Accounts receivable (21) 33 65
Inventory (56) 27 (82)
Prepaid expenses and other current assets 16 (110) (129)
Deferred financing costs 48
Other assets (11)
Accounts payable 377 (17) 228
Accrued liabilities excluding accrued interest on convertible note 415 530 (416)
Deferred revenue 96 32
Deferred rent 25 26 (23)
Net cash used in operating activities (8,671) (5,522) (7,023)
Investing activities:      
Purchase of property and equipment (136) (125)
Cash acquired in reverse merger 19,017
Payment of transaction costs of reverse merger (96)
Purchase of short-term investments (1,800)
Maturity of short-term investments 1,800
Net provided by (used in) in investing activities (136) 18,921 (125)
Financing activities:      
Proceeds from the exercise of convertible preferred stock warrants 27
Proceeds from issuance of convertible notes and warrants 4,374 7,435
Proceeds from the exercise of common stock options 144 22 59
Net cash provided by financing activities 144 4,396 7,521
Net increase (decrease) in cash and cash equivalents (8,663) 17,795 373
Cash and cash equivalents at beginning of period 21,352 3,557 3,184
Cash and cash equivalents at end of period 12,689 21,352 3,557
Supplemental disclosure of noncash investing and financing activities:      
Exchange of convertible preferred stock warrants for common stock 25
Conversion of convertible shareholder notes and related interest payable 12,156 7,781
Reclassification of convertible shareholder notes derivative liability 2,268
Conversion of preferred stock $ 46,030